Company intelligence / Profile preview

BostonGene Japan

Tokyo, Japan

Ownership: Private
Development stage: Other

Overview

BostonGene Japan offers clinically validated, AI-powered genomic and immune profiling (such as Tumor Portrait™), supporting treatment decisions and biomarker discovery for precision oncology. This includes widely adopted diagnostic services in the US and now increasing access across Japan through new academic and clinic partnerships[1][2][5][7].

Therapeutic areas: Oncology
Modalities: Diagnostic testAI-powered computational analysis
Industry: Molecular Diagnostics

Partnerships

NEC (NEC Corporation)Japan Industrial PartnersFujita Health University

Beyond the preview

Go deeper on BostonGene Japan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BostonGene Japan.

Explore the full profile